Paper30991027
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
Huang Y and 27 others. Cancer Cell, 2019. Cited by 769 papers, by iCite.
Cite this record
ConductScience Library. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Papers, record 30991027. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30991027
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | Major topic |
| Antineoplastic Agents | Major topic |
| Enzyme Inhibitors | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Animals | |
| Apoptosis | |
| Cell Cycle Checkpoints | |
| Cell Differentiation | |
| Cell Proliferation | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Methylation | |
| Mice, Inbred BALB C | |
| Mice, Inbred NOD | |
| Mice, Transgenic | |
| Molecular Targeted Therapy | |
| Protein Conformation | |
| RNA, Messenger | |
| Rats, Sprague-Dawley | |
| Signal Transduction | |
| Structure-Activity Relationship | |
| U937 Cells | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL131444 | NHLBI NIH HHS | United States | R01HL131444 | PubMed | NIH RePORTER |
| R01 CA236399 | NCI NIH HHS | United States | R01CA236399 | PubMed and NIH | NIH RePORTER |
| R50 CA211404 | NCI NIH HHS | United States | R50CA211404 | PubMed | NIH RePORTER |
| R01 DK124116 | NIDDK NIH HHS | United States | R01DK124116 | PubMed | NIH RePORTER |
| R01 CA214965 | NCI NIH HHS | United States | R01CA214965 | PubMed and NIH | NIH RePORTER |
| R01 DK107615 | NIDDK NIH HHS | United States | R01DK107615 | PubMed | NIH RePORTER |
| R56 DK120282 | NIDDK NIH HHS | United States | R56DK120282 | PubMed and NIH | NIH RePORTER |
| R01 CA243386 | NCI NIH HHS | United States | R01CA243386 | PubMed | NIH RePORTER |
| R01 CA178454 | NCI NIH HHS | United States | R01CA178454 | PubMed | NIH RePORTER |
| R01 CA211614 | NCI NIH HHS | United States | R01CA211614 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 30991023 | The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells. | https://conductscience.org/library/papers/30991023 |
Source PubMed
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29535189 | Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d. | Genes Dev | 2018 | https://conductscience.org/library/papers/29535189 | PubMed |
| 2 | 174715 | 5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA. | Biochemistry | 1976 | https://conductscience.org/library/papers/174715 | PubMed |
| 3 | 28809393 | Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. | Cell Res | 2017 | https://conductscience.org/library/papers/28809393 | PubMed |
| 4 | 15299374 | The CCP4 suite: programs for protein crystallography. | Acta Crystallogr D Biol Crystallogr | 1994 | https://conductscience.org/library/papers/15299374 | PubMed |
| 5 | 28106076 | Cytoplasmic m6A reader YTHDF3 promotes mRNA translation. | Cell Res | 2017 | https://conductscience.org/library/papers/28106076 | PubMed |
| 6 | 23812591 | Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. | Nature | 2013 | https://conductscience.org/library/papers/23812591 | PubMed |
| 7 | 9597150 | Cyclooxygenases 1 and 2. | Annu Rev Pharmacol Toxicol | 1998 | https://conductscience.org/library/papers/9597150 | PubMed |
| 8 | 20686503 | AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. | Leukemia | 2010 | https://conductscience.org/library/papers/20686503 | PubMed |
| 9 | 30487554 | Cap-specific, terminal N6-methylation by a mammalian m6Am methyltransferase. | Cell Res | 2019 | https://conductscience.org/library/papers/30487554 | PubMed |
| 10 | 27015802 | Rhein Inhibits AlkB Repair Enzymes and Sensitizes Cells to Methylated DNA Damage. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27015802 | PubMed |
| 11 | 24616105 | Crystal structures of the human RNA demethylase Alkbh5 reveal basis for substrate recognition. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24616105 | PubMed |
| 12 | 24504543 | A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. | ChemMedChem | 2014 | https://conductscience.org/library/papers/24504543 | PubMed |
| 13 | 25569111 | Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. | Science | 2015 | https://conductscience.org/library/papers/25569111 | PubMed |
| 14 | 21741596 | Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21741596 | PubMed |
| 15 | 28684529 | Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox. | Cancer Res | 2017 | https://conductscience.org/library/papers/28684529 | PubMed |
| 16 | 29186125 | Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. | Nature | 2017 | https://conductscience.org/library/papers/29186125 | PubMed |
| 17 | 18775698 | Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18775698 | PubMed |
| 18 | 21079590 | Grand challenge commentary: RNA epigenetics? | Nat Chem Biol | 2010 | https://conductscience.org/library/papers/21079590 | PubMed |
| 19 | 26046440 | N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. | Cell | 2015 | https://conductscience.org/library/papers/26046440 | PubMed |
| 20 | 16621364 | High throughput microsomal stability assay for insoluble compounds. | Int J Pharm | 2006 | https://conductscience.org/library/papers/16621364 | PubMed |
Cited by572
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 769 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985451 | m6A modification in allergic airway diseases: a narrative review from a cellular perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/42985451 | PubMed |
| 42951963 | Pharmacological inhibition of METTL1 as a therapy against solid and blood cancers. | Nature | 2026 | https://conductscience.org/library/papers/42951963 | PubMed |
| 42942089 | Epigenetic Mechanisms in Neurodegenerative Diseases: From Genetic Regulation to Therapeutic Potential. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942089 | PubMed |
| 42918854 | Molecular functions, cellular responses and pathological implications of the RNA modification N6-methyladenosine. | Nat Rev Mol Cell Biol | 2026 | https://conductscience.org/library/papers/42918854 | PubMed |
| 42866557 | FTO-Mediated m6A Demethylation in Insulin Resistance and Type 2 Diabetes: Tissue-Specific Mechanisms - a Narrative Review. | Diabetes Metab Syndr Obes | 2026 | https://conductscience.org/library/papers/42866557 | PubMed |
| 42860591 | Hepatic Lipid Stress Drives Metabolic Dysfunction-Associated Steatohepatitis Progression through FTO O-GlcNAcylation-Induced m6A Demethylation of HRAS. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42860591 | PubMed |
| 42811101 | The cellular landscape of druggable RNA-binding proteins. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/42811101 | PubMed |
| 42792700 | FTO-Driven m6A Demethylation of TNC Promotes Epithelial-Mesenchymal Transition and Gastric Cancer Metastasis. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792700 | PubMed |
| 42779519 | FTO/m6A Regulate Prenatal Nicotine-Induced eNOS Uncoupling and BP Susceptibility. | Hypertension | 2026 | https://conductscience.org/library/papers/42779519 | PubMed |
| 42764990 | Targeting the SETD2-FTO-KIT pathway as a pharmacological strategy for TKI-refractory GIST. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42764990 | PubMed |
| 42756925 | m6A-Targeted Cancer Therapy: Molecular Targets, Inhibitors, and Nanodelivery Strategies. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42756925 | PubMed |
| 42735908 | Synthesis and Binding Affinity Insights of 2-Phenyl-1H-Benzimidazole Inhibitors Targeting FTO by Spectroscopic Characterization and Molecular Docking. | J Mol Recognit | 2026 | https://conductscience.org/library/papers/42735908 | PubMed |
| 42729906 | Rewriting the brain: m6A RNA methylation as an emerging epitranscriptomic regulator in major depressive disorder. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42729906 | PubMed |
| 42684666 | Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability. | BioDrugs | 2026 | https://conductscience.org/library/papers/42684666 | PubMed |
| 42683026 | Oxidative stress-driven epigenetic reprogramming of immune cells in COPD: from epitranscriptomic and metabolic crosstalk to treatable traits. | Front Immunol | 2026 | https://conductscience.org/library/papers/42683026 | PubMed |
| 42672728 | How Epitranscriptomic Machinery Senses Environmental Cues. | Adv Biol (Weinh) | 2026 | https://conductscience.org/library/papers/42672728 | PubMed |
| 42666037 | AL398, A Novel NSUN6 Inhibitor, Attenuates Epithelial-Mesenchymal Transition and Metastasis in Endometrial Cancer by Abrogating m5C-Dependent Stabilization of Snail mRNA. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42666037 | PubMed |
| 42606187 | Epigenetic Factor Dysregulation and Distinct Expression Signatures in Retinoblastoma: A Transcriptomic Analysis. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42606187 | PubMed |
| 42548706 | Reader-dependent functional duality of FTO: a context-switching node at the intersection of immune evasion and therapeutic resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548706 | PubMed |
| 42541138 | The role, regulatory mechanisms, and therapeutic implications of FTO in gastrointestinal cancer. | Genes Dis | 2026 | https://conductscience.org/library/papers/42541138 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30991027
GET https://conductscience.org/api/papers/v1/30991027/authors?page=2